Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(JAGSNPHARM) Jagsonpal Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Jagsonpal Pharmaceuticals | (JAGSNPHARM) share price targets

Complete technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM) by charts plus indicators, forecast predictions and share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Jagsonpal Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-03-20 View latest technical analysis

10 day averaged volume of Jagsonpal Pharmaceuticals is 84595

Date	Daily Closing Price	Open	High	Low	Volume
20 Thu Mar 2025	223.25	223.00	227.08	217.25	1.09 times
19 Wed Mar 2025	221.25	216.90	225.51	215.30	1.288 times
18 Tue Mar 2025	216.90	205.56	219.00	205.56	1.31 times
17 Mon Mar 2025	205.56	202.50	208.95	201.99	1.21 times
13 Thu Mar 2025	204.96	208.50	212.19	203.16	0.806 times
12 Wed Mar 2025	209.59	210.95	212.99	206.48	1.336 times
11 Tue Mar 2025	208.18	208.10	211.93	205.10	0.92 times
10 Mon Mar 2025	212.84	218.00	223.90	212.05	0.555 times
07 Fri Mar 2025	220.22	216.50	221.59	216.50	0.802 times
06 Thu Mar 2025	216.99	215.61	220.00	215.61	0.823 times

My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 219.1, but if it comes below 219.1, then a intra day sell could be more profitable.
If you take a sell trade below 219.1, then use 219.1 as stoploss and 213.38 as target. However if you take a buy trade in stock , then use 219.1 as stoploss and 225.9 as target.

Share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Target Type	Value
Downside Target	196.35
Downside Target	201.99
Downside Target	207.65
Downside Target	221.36
Upside Target	227.08
Upside Target	231.10
Upside Target	284.36
Upside Target	525.75
Upside Target	584.25
Upside Target	695.00
Upside Target	814.25
Upside Target	820.10

Intraday share price targets for Jagsonpal Pharmaceuticals (JAGSNPHARM)

Target Type	Value
Downside Intraday Target	207.8
Downside Intraday Target	192.35
Upside Intraday Target	232.89
Upside Intraday Target	242.53
Downside Intraday Target	217.44

Weekly technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Date	Weekly Closing Price	Open	High	Low	Volume
20 Thu Mar 2025	223.25	202.50	227.08	201.99	1.355 times
13 Thu Mar 2025	204.96	218.00	223.90	203.16	0.607 times
07 Fri Mar 2025	220.22	206.80	221.59	196.36	0.657 times
28 Fri Feb 2025	206.30	215.90	221.36	202.01	0.646 times
21 Fri Feb 2025	219.64	228.95	231.10	207.65	0.448 times

Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Date	Monthly Closing Price	Open	High	Low	Volume
20 Thu Mar 2025	223.25	206.80	227.08	196.36	0.179 times
28 Fri Feb 2025	206.30	250.88	284.36	202.01	0.678 times
31 Fri Jan 2025	249.60	610.85	695.00	196.35	3.558 times
31 Tue Dec 2024	610.85	762.00	814.25	584.25	0.634 times

Scroll below to view daily charts

Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

Price action analysis of Jagsonpal Pharmaceuticals ( (JAGSNPHARM) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Jagsonpal Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Jagsonpal Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Jagsonpal Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Jagsonpal Pharmaceuticals in short term and BUY signal is strong.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Jagsonpal Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 214.13 and Jagsonpal Pharmaceuticals (JAGSNPHARM) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Jagsonpal Pharmaceuticals (JAGSNPHARM) stock. Volume based technical analysis of Jagsonpal Pharmaceuticals (JAGSNPHARM) stock is negative.

Jagsonpal Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.